Integrated Analysis of Mismatch Repair System in Malignant Astrocytomas
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrated Analysis of Mismatch Repair System in Malignant Astrocytomas
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 9, Pages e76401
Publisher
Public Library of Science (PLoS)
Online
2013-09-21
DOI
10.1371/journal.pone.0076401
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Malignant glioma grade 3 and 4: How relevant is timing of radiotherapy?
- (2012) Friederike M. Wehming et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Screening Patients With Colorectal Cancer for Lynch Syndrome: What Are We Waiting For?
- (2012) Fay Kastrinos et al. JOURNAL OF CLINICAL ONCOLOGY
- Primary brain tumours in adults
- (2012) Damien Ricard et al. LANCET
- Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas
- (2011) Jörg Felsberg et al. INTERNATIONAL JOURNAL OF CANCER
- Microsatellite Instability in Pediatric High Grade Glioma Is Associated with Genomic Profile and Differential Target Gene Inactivation
- (2011) Marta Viana-Pereira et al. PLoS One
- Defective Mismatch Repair, Microsatellite Mutation Bias, and Variability in Clinical Cancer Phenotypes
- (2010) S. N. Shah et al. CANCER RESEARCH
- The expression of mismatch repair proteins MLH1, MSH2 and MSH6 correlates with the Ki67 proliferation index and survival in patients with recurrent glioblastoma
- (2010) Andreas M. Stark et al. NEUROLOGICAL RESEARCH
- Mismatch-repair protein MSH6 is associated with Ku70 and regulates DNA double-strand break repair
- (2010) Ankita Shahi et al. NUCLEIC ACIDS RESEARCH
- Specific Variants in the MLH1 Gene Region May Drive DNA Methylation, Loss of Protein Expression, and MSI-H Colorectal Cancer
- (2010) Miralem Mrkonjic et al. PLoS One
- MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance
- (2009) S. Yip et al. CLINICAL CANCER RESEARCH
- Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications
- (2009) HT Lynch et al. CLINICAL GENETICS
- Anaplastic Glioma: How to Prognosticate Outcome and Choose a Treatment Strategy
- (2009) Lisa M. DeAngelis JOURNAL OF CLINICAL ONCOLOGY
- Management of extracolonic tumours in patients with Lynch syndrome
- (2009) Jan J Koornstra et al. LANCET ONCOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
- (2009) Michael Weller et al. Nature Reviews Neurology
- Analysis of microsatellite instability in medulloblastoma
- (2009) Marta Viana-Pereira et al. NEURO-ONCOLOGY
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mismatch Repair Deficiency Does Not Mediate Clinical Resistance to Temozolomide in Malignant Glioma
- (2008) J. A. Maxwell et al. CLINICAL CANCER RESEARCH
- MLH1 −93G>A promoter polymorphism and risk of mismatch repair deficient colorectal cancer
- (2008) James M. Allan et al. INTERNATIONAL JOURNAL OF CANCER
- The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome
- (2008) Patrice Watson et al. INTERNATIONAL JOURNAL OF CANCER
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Classification of ambiguous mutations in DNA mismatch repair genes identified in a population-based study of colorectal cancer
- (2007) Rebecca A. Barnetson et al. HUMAN MUTATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started